#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12658	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2475	630.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1600	1600	C	756	C,A	755,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12658	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2475	630.0	0	HET	.	.	.	C611T,G	.	611	611	C	1027	1027	C	804	C,T,G	614,189,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20656	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4008	642.1	0	.	n	.	0	T695C	SNP	695	695	T	1249	1249	C	729	C,T,A	727,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20656	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4008	642.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1891	1891	A	842	A	841	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20656	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4008	642.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2525	2525	C	669	C,A	667,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20656	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4008	642.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3151	3151	T	731	T,G	730,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	20656	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4008	642.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2599	2599	A	715	A	715	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1864	folP	852	852	100.0	folP.l15.c4.ctg.1	1930	120.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1246	1248	AGC	175;171;169	A;G;C	175;171;169	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3863	158.2	1	SNP	p	S91F	0	.	.	271	273	TCC	857	859	TCC	176;174;173	T;C;C	176;174;173	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3863	158.2	1	SNP	p	D95N	0	.	.	283	285	GAC	869	871	GAC	177;174;175	G,A;A;C,T	176,1;174;174,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4900	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3863	158.2	1	SNP	p	D95G	0	.	.	283	285	GAC	869	871	GAC	177;174;175	G,A;A;C,T	176,1;174;174,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1760	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1932	113.8	1	SNP	p	G45D	1	.	.	133	135	GAC	780	782	GAC	219;219;215	G;A,G,C;C	219;217,1,1;215	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1022	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1452	87.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	170.8	1	SNP	p	D86N	0	.	.	256	258	GAC	823	825	GAC	222;223;220	G;A,C,G;C,G	222;219,3,1;219,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	170.8	1	SNP	p	S87I	0	.	.	259	261	AGT	826	828	AGT	221;219;217	A;G;T,C	221;219;216,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	170.8	1	SNP	p	S87R	0	.	.	259	261	AGT	826	828	AGT	221;219;217	A;G;T,C	221;219;216,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	170.8	1	SNP	p	S87W	0	.	.	259	261	AGT	826	828	AGT	221;219;217	A;G;T,C	221;219;216,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4562	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	170.8	1	SNP	p	S88P	0	.	.	262	264	TCC	829	831	TCC	219;218;226	T;C;C	219;218;226	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3808	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3120	152.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1782	1784	GGC	199;195;193	G;G;C	199;195;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1374	1376	GCA	215;217;216	G,A;C,T,A;A	214,1;215,1,1;216	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1377	1379	ATC	213;213;214	A,C;T;C	212,1;213;214	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1389	1391	GTG	224;225;228	G,T;T,G;G	223,1;224,1;228	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1389	1391	GTG	224;225;228	G,T;T,G;G	223,1;224,1;228	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1893	1895	ACC	165;166;168	A;C,G;C	165;165,1;168	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1947	1949	GCG	175;174;176	G;C,G;G,T	175;173,1;175,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1947	1949	GCG	175;174;176	G;C,G;G,T	175;173,1;175,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2070	2072	GGC	178;179;179	G,C;G;C	177,1;179;179	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2079	2081	GGC	173;177;178	G;G;C	173;177;178	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3372	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2832	148.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2097	2099	CCG	177;174;172	C,T;C,T,A;G	176,1;172,1,1;172	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4914	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3624	169.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2296	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2289	125.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	764	764	C	159	C	159	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	524	526	GGA	196;196;200	G;G;A	195;195;198	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	V75I	NONSYN	223	225	GTT	605	607	ATT	200;200;200	A,G;T;T	199,1;200;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	647	649	AGC	205;204;204	A;G;C	205;204;204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	V98I	NONSYN	292	294	GTC	674	676	ATC	192;188;186	A,C;T,G;C	191,1;186,2;186	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	739	740	CG	189;188	C;G	189;188	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	742	744	CAG	188;188;191	C;A;G	188;188;191	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	746	748	AAA	188;189;188	A,C;A;A	187,1;189;188	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	809	811	GAA	206;205;200	G;A,G;A	206;204,1;200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	833	835	GCA	201;201;205	G;C;A,G	201;201;204,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1019	1021	TCA	233;232;233	T,A,C;C,A;A	230,2,1;231,1;233	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1139	1141	CAA	162;160;157	C;A;A	162;160;157	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	.	INDELS	760	762	ACA	1143	1147	ATCAA	158;157;155;154;155	A;T;C;A,G;ATT,AT	158;157;155;153,1;152,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	.	INDELS	763	764	TG	1150	1152	AGT	158;161;160	A;G;T	158;161;160	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1157	1159	GAT	161;160;160	G,T;A;T	160,1;160;160	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1265	1267	AGT	198;197;199	A,C;G;T	197,1;197;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1271	1273	GAC	208;210;210	G;A;C	208;210;210	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1274	1276	TAC	212;211;208	T;A,C;C	212;210,1;208	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	1	SNP	p	G120K	1	.	.	358	360	AAG	739	741	CGG	189;188;187	C;G;G	189;188;187	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	1	SNP	p	A121D	1	.	.	361	363	GAC	742	745	CGC	188;191;191	C;G;C	188;191;191	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2242	porB1b	1041	1041	97.23	porB1b.l15.c30.ctg.1	1564	173.0	1	SNP	p	D121N	0	.	.	361	363	GAC	742	745	CGC	188;191;191	C;G;C	188;191;191	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8046	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5184	193.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2162	2164	AAT	221;218;220	A;A;T,G	221;218;219,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1190	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1490	99.7	1	SNP	p	V57M	1	.	.	169	171	ATG	773	775	ATG	230;231;234	A,G;T;G,T	229,1;231;233,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
